🇺🇸 FDA
Patent

US 10907151

Compositions and methods for treating or preventing lupus

granted A61KA61K2039/505A61K31/519

Quick answer

US patent 10907151 (Compositions and methods for treating or preventing lupus) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K31/519, A61K31/5377, A61K31/5383